Men With Inflammatory Joint Diseases Seem to Have More Children
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 24, 2024 -- Men with inflammatory joint diseases (IJDs) have a higher number of children and are less likely to be childless, according to a study published online Jan. 22 in the Annals of Rheumatic Disease.
Gudrun David Sigmo, from Stavanger University Hospital in Norway, and colleagues conducted a nationwide, population-based, retrospective cohort study involving 10,865 male patients with IJDs who were matched with 54,325 men without IJDs on birth year and county of residence. The mean number of children per man was compared between the groups, and the proportion of childless men was quantified.
The researchers found that the mean number of children per man was 1.80 and 1.69 in the patient and comparison groups, respectively; 21 and 27 percent of participants in the patient and comparison groups, respectively, were childless. Except for those diagnosed at age 0 to 19 years, the finding of less childlessness and higher number of children per man remained consistent across age at diagnosis. The most pronounced difference in childlessness was among men diagnosed after 2000, especially for those diagnosed at age 30 to 39 years (22 versus 32 percent).
"Based on the large study population, matched population subjects and methods of analysis, we have little reason to doubt our findings," the authors write. "Factors associated with developing or having an IJD might influence fertility and need to be further investigated."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-25 02:15
Read more
- Generic Medications Can Keep OOP Costs Down for Neurological Conditions
- Early TAVR Beneficial for Asymptomatic Severe Aortic Stenosis
- Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising
- Bird Flu Infection Confirmed in a Pig for First Time in U.S.
- ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
- PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions